NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Prabhudas Lilladher Report
We attended the analyst meet of VIP industries Ltd. wherein management unveiled plans on product innovation (new launches were on display; premiumisation, leadership and supply chain management.
On fruition, the revival strategy is likely to result in market share gains while Ebitda margin is likely to improve to 15% from H2 FY25E once warehousing, freight and accelerated spends on e-com stabilize.
We broadly maintain our estimates and expect sales/Ebitda compound annual growth rate of 12%/37% over FY24E-FY26E on the back of said revival plan.
We upgrade VIP Industries to a Buy (earlier Hold) with a revised target price of Rs 603 (earlier Rs 589) after assigning a multiple of 33 times (earlier 38 times) as we roll forward to FY26E.
Our upgrade is driven by 30% correction over last six months and the ensuing valuation comfort (VIP trades at ~17% discount to its LPA history of past 10 years).
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
VIP Industries Q4 Results Review - Poor Bangladesh Operation Impede Performance: IDBI Capital
May 13, 2024
Indostar Capital Finance Q4 - Turnaround In Motion; Access To Liabilities A Key Monitorable: Motilal Oswal
May 02, 2024
Sun Pharma - ‘Specialty’ Way Of Driving Growth Prospects: Motilal Oswal
Apr 24, 2024
Bajaj Auto Q4 Results Review - Margins Maintained Despite Lower Sequential Volumes: Motilal Oswal
Apr 19, 2024
POPULAR